Skip to main content
Premium Trial:

Request an Annual Quote

Clarification: In the article Will the Private Sector Fulfill Promises or Provide HUPO with Opportunity in 2002? published in the January 7, 2002, issue of ProteoMonitor

Premium

Clarification: In the article “Will the Private Sector Fulfill Promises or Provide HUPO with Opportunity in 2002?” published in the January 7, 2002, issue of ProteoMonitor, a quote from HUPO president Samir Hanash was paraphrased in a way that indicated that he believed companies such as Celera and Myriad Genetics had so far delivered little in the area of proteomics. In a subsequent letter to ProteoMonitor Hanash said that he felt his remarks had been misconstrued, and that by indicating that he believed companies such as Celera and Myriad Genetics had delivered little the article implied that he knows they have accomplished little. Hanash said, with regard to Celera and Myriad: “I do not know what they have accomplished and ... so I could not possibly have said that I know they have accomplished very little. I have the highest regards for the effort that Celera has put out and for the people associated with it.”

Hanash said that it was not his intention to disparage the proteomics efforts of private sector companies, but “to defend the legitimate contributions that academia could make in proteomics” and to point out “that the field is much bigger than any group could deliver no matter how ambitious they are.”

 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.